Traders Purchase Large Volume of Call Options on Amarin Co. plc (AMRN)
Shares of Amarin Co. plc (NASDAQ:AMRN) was the target of some unusual options trading activity on Monday. Investors acquired 38,228 call options on the company, AnalystRatings.NET reports. This represents an increase of 179% compared to the average daily volume of 13,680 call options.
A number of analysts have recently weighed in on AMRN shares. Analysts at Oppenheimer cut their price target on shares of Amarin Co. plc from $7.00 to $6.00 in a research note to investors on Monday. They now have a “market perform” rating on the stock. Separately, analysts at Aegis reiterated a “buy” rating on shares of Amarin Co. plc in a research note to investors on Monday. They now have a $30.00 price target on the stock. Finally, analysts at Leerink Swann reiterated an “outperform” rating on shares of Amarin Co. plc in a research note to investors on Monday. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average target price of $12.05.
Shares of Amarin Co. plc (NASDAQ:AMRN) opened at 5.01 on Tuesday. Amarin Co. plc has a 52 week low of $4.50 and a 52 week high of $12.96. The stock has a 50-day moving average of $6.54 and a 200-day moving average of $6.43. The company’s market cap is $864.8 million.
Amarin Co. plc (NASDAQ:AMRN) last released its earnings data on Thursday, August 8th. The company reported ($0.26) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.38) by $0.12. The company had revenue of $5.50 million for the quarter. On average, analysts predict that Amarin Co. plc will post $-1.37 earnings per share for the current fiscal year.
Amarin Corporation plc (NASDAQ:AMRN) is a late-stage biopharmaceutical -company with expertise in lipid science focused on the treatment of cardiovascular disease.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.